Literature DB >> 7379668

Carcinoma of the colon and rectum complicating chronic ulcerative colitis.

J A van Heerden, R W Beart.   

Abstract

Patients with pancolonic chronic ulcerative colitis are at increased risk to develop carcinoma of the colon. Controversy continues, however, as to whether this carcinoma is more "virulent" than "type ordinaire" carcinoma of the colon and as to the best way to manage these patients. This study reviews the characteristics and survival of 70 patients with cancer of the colon superimposed on chronic ulcerative colitis. Patients with carcinoma identified incidentally during prophylactic colectomy for chronic ulcerative colitis fared well (5-year survival of 72 per cent), while those with clinical symptoms or radiographic suggestion of cancer had a poor survival rate (5-year survival of 35 per cent). Patients with panproctocolitis, 10 years of disease, and early onset of disease are most likely to have cancer superimposed on chronic ulcerative colitis. This cancer is likely to have a poorer prognosis than type ordinaire cancer of the colon. Prophylactic proctocolectomy should be considered before evidence suggesting carcinoma develops.

Entities:  

Mesh:

Year:  1980        PMID: 7379668     DOI: 10.1007/bf02587618

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  22 in total

Review 1.  Screening for colorectal cancer in ulcerative colitis: dubious benefits and high costs.

Authors:  S Gyde
Journal:  Gut       Date:  1990-10       Impact factor: 23.059

Review 2.  Inflammatory bowel disease and cancer.

Authors:  B Cola
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

3.  Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: risks and benefits.

Authors:  Bianca W Chang; Aryavarta M S Kumar; Shlomo A Koyfman; Matthew Kalady; Ian Lavery; May Abdel-Wahab
Journal:  Int J Colorectal Dis       Date:  2015-01-08       Impact factor: 2.571

4.  Clinical outcome of IBD-associated versus sporadic colorectal cancer: a matched-pair analysis.

Authors:  Bernhard W Renz; Wolfgang E Thasler; Gerhard Preissler; Tobias Heide; Philippe N Khalil; Michael Mikhailov; Karl-Walter Jauch; Martin E Kreis; Markus Rentsch; Axel Kleespies
Journal:  J Gastrointest Surg       Date:  2013-03-09       Impact factor: 3.452

5.  Survival of Colorectal Cancer in Patients With or Without Inflammatory Bowel Disease: A Meta-Analysis.

Authors:  Baochi Ou; Jingkun Zhao; Shaopei Guan; Aiguo Lu
Journal:  Dig Dis Sci       Date:  2015-10-30       Impact factor: 3.199

6.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

Review 7.  Cancer in inflammatory bowel disease.

Authors:  A J Greenstein; A Sugita; Y Yamazaki
Journal:  Jpn J Surg       Date:  1989-11

8.  Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease.

Authors:  Jordan Axelrad; Anuja Kriplani; Umut Ozbek; Noam Harpaz; Jean-Frederic Colombel; Steven Itzkowitz; Randall F Holcombe; Celina Ang
Journal:  Clin Colorectal Cancer       Date:  2016-09-20       Impact factor: 4.481

9.  Review of clinical aspects of cancer of the colon in patients with ulcerative colitis.

Authors:  R P MacDermott
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

10.  Survival with carcinoma arising in mucosal ulcerative colitis.

Authors:  I C Lavery; R A Chiulli; D G Jagelman; V W Fazio; F L Weakley
Journal:  Ann Surg       Date:  1982-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.